Recall: Lupin Pharmaceuticals Ceftriaxone For Injection USP, 250mg, 500mg, 1g And 2g
On 2019-01-05, the FDA announced that Lupin Pharmaceuticals is conducting a recall on Ceftriaxone For Injection USP, 250mg, 500mg, 1g And 2g due to possible contamination with foreign matter. The recalled products were sold under the brand name(s) Lupin Pharmaceuticals during an unspecified time period throughout the regions shown in the map below.
In recent months, there have been 2 drugs recalls due to potential contamination, including homeopathic aqueous-based medicines, homeopathic drug products (liquid) and more. Additionally, there have been 19 drug and medical device recalls due to other health hazards as well as 90 food recalls.
Company Contact Information:
Name: Lupin Pharmaceuticals
Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.
Detailed Recall Information
Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.
Product Description: Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g
Brand Name(s): Lupin Pharmaceuticals
Reason for Recall: Foreign Matter Contamination
Official Recall Date: 2019-01-05
Additional information provided by the FDA.gov:
Lupin Pharmaceuticals, Inc. is voluntarily recalling 5 lots of Ceftriaxone for Injection, USP, 250mg, 10 lots of Ceftriaxone for Injection, USP, 500mg, 24 lots of Ceftriaxone for Injection, USP, 1g and 3 lots of Ceftriaxone for Injection, USP 2g, to the hospital/physician level. The products have been found to contain visual grey particulate matter in reconstituted vials Read More.
More information may be available at FDA.gov
Latest Safety Recalls
Select image for details, including additional styles.
Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.